Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract

References

1. Anderson M. J., Gull K., Denning D. W. 1996; Molecular typing by random amplification of polymorphic DNA and M13 Southern hybridization of related paired isolates of Aspergillus fumigatus . J Clin Microbiol 34:87–93
   [Google Scholar]
2. Ascioglu S., Rex J. H., de Pauw B., Bennett J. E. & 16 other authors; 2002; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hemopoeitic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14 [CrossRef]
   [Google Scholar]
3. Austwick P. K. C. 1965; Pathogenicity. In The Genus Aspergillus pp  82–126 Edited by Raper K. B., Fennell D. I. Baltimore: Williams & Wilkins;
   [Google Scholar]
4. Buchheidt D., Skladny H., Baust C., Hehlmann R. 2000; Systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies: current serological and molecular diagnostic methods. Chemotherapy 46:219–228 [CrossRef]
   [Google Scholar]
5. Denning D. W., Stevens D. A. 1990; Antifungal and surgical treatment of invasive aspergillosis. Review of 2,121 published cases. Rev Infect Dis 12:1147–1201 [CrossRef]
   [Google Scholar]
6. Denning D. W., Kibbler C. C., Barnes R. A. 2003; British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 3:230–240 [CrossRef]
   [Google Scholar]
7. Hori A., Kami M., Kishi Y., Mashid U., Matsumura T., Kashima T. 2002; Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect 50:175–182 [CrossRef]
   [Google Scholar]
8. Lass-Florl C., Kofler G., Kropshofer G., Hermans J., Kreczy A., Dierich M. P., Niederwieser D. 1997; In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 40:401–414 [CrossRef]
   [Google Scholar]
9. Lee S. B., Taylor J. W. 1990; Isolation of DNA from fungal mycelia and single spores. In PCR Protocols: a Guide to Methods and Applications pp  282–287 Edited by Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. San Diego: Academic Press;
   [Google Scholar]
10. Lin D., Lehmann P. F., Hamory B. H., Padhye A. A., Durry E., Pinner R. W., Lasker B. A. 1995; Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus . J Clin Microbiol 33:1596–1601
    [Google Scholar]
11. National Committee for Clinical Laboratory Standards 2002 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi . Approved standard M38-A Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
12. Paterson P. J., Seaton S., Prentice H. G., Kibbler C. C. 2003; Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J Antimicrob Chemother 52:873–876 [CrossRef]
    [Google Scholar]
13. Prescott R. J., Harris M., Banerjee S. S. 1992; Fungal infections of the small and large intestine. J Clin Pathol 45:806–811 [CrossRef]
    [Google Scholar]
14. Richter S., Cormican M. G., Pfaller M. A., Lee C. K., Gingrich R., Rinaldi M. G., Sutton D. A. 1999; Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol 37:1154–1160
    [Google Scholar]
15. Schell W. A., Perfect J. R. 1996; Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 34:1333–1336
    [Google Scholar]
16. Soll D. R. 2000; The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13:332–370 [CrossRef]
    [Google Scholar]
17. Srivastava V. M., Krishnaswami H., Srivastava A., Dennison D., Chandy M. 1996; Infections in haematological malignancies: an autopsy study of 72 cases. Trans R Soc Trop Med Hyg 90:406–408 [CrossRef]
    [Google Scholar]
18. Stevens D. A., Kan V. L., Judson M. A. & 7 other authors; 2000; Practice guidelines for diseases caused by Aspergillus . Clin Infect Dis 30:696–709 [CrossRef]
    [Google Scholar]
19. Working Party of British Society for Antimicrobial Chemotherapy; 1993; Chemoprophylaxis for candidiosis and aspergillosis in neutropenia and transplantation – review and recommendations. J Antimicrob Chemother 32:5–21 [CrossRef]
    [Google Scholar]
20. Wright J. A., Bradfield S. M., Park J. R., Hawkins D. S. 2003; Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases. J Pediatr Hematol Oncol 25:286–291 [CrossRef]
    [Google Scholar]